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ABSTRACT
	 Background
	 Postoperative cognitive dysfunction is a significant complication, but the mechanisms underlying this 
condition and its impact on the brain network are not fully elucidated. The goals of this study were to verify 
how the transcriptional network in the hippocampus of aged mice changes following sevoflurane/surgery-induced 
stress and to substantiate how dexmedetomidine influences the cognitive function and mRNA changes in the 
hippocampus.
	 Materials and methods
	 We first performed transcriptome analysis to confirm the changes of mRNA expression in the Naïve and 
Ope (surgery under sevoflurane) groups. Then, the mice were divided into four groups: Naïve, Sevo (sevoflurane 
exposure), Ope, and Dex (dexmedetomidine injection before surgery). We selected the Mapt gene, the upregulated 
expression of which has been observed in our transcriptome analysis and in neurodegenerative disorders, as 
the target gene and investigated whether the changes in its expression occurred in the hippocampus using quantitative 
reverse transcription polymerase chain reaction (qRT-PCR). The cognitive function of mice was evaluated via 
the Barnes Maze test. 
	 Results
	 In the qRT-PCR analysis, Mapt expression was significantly upregulated (2.60 ± 0.77 in mice from the Ope group 
vs. 1.00 ± 0.11 in mice from the Naïve group [mean ± SD for fold change]; p<0.01). Dexmedetomidine significantly 
attenuated the sevoflurane/surgery-induced upregulation of Mapt expression in the hippocampus (0.88 ± 0.32; 
p<0.01). Sevoflurane/surgery-induced stress also increased the time to identify the target box, and dexmedetomidine 
treatment inhibited the time extension 7, 14, and 28 days after the surgery.
	 Conclusions
	 Dexmedetomidine attenuates the sevoflurane/surgery-induced cognitive deficit and Mapt expression in 
the hippocampus of aged mice.
(Accepted November 6, 2019)
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1.　Introduction
 Postoperative cognitive dysfunction (POCD) is an 
important complication after surgery in clinical 
settings 1）. POCD has a negative impact on the quality 
of life of the affected patients and is more frequent and 
severe among elderly patients 2-4）. In several human 
studies, general anesthetics or/and surgical procedures 
cause systemic inflammation 5）, neuronal stress 6）, 
cognitive dysfunction, and even increase mortality 7）. In 
addition, aging may be the most critical risk factor for 
POCD 8-10）, but the details underlying the mechanism 
of POCD and its impact on brain networks are not 
fully understood. 
 Tau proteins, which are observed in neurodegenerative 
disorders, belong to the microtubule-associated protein 
tau (Mapt) family and play a significant role in the 
assembly of microtubules in during aging 11）. In vitro, 
plaque formation and tauopathy seen in Alzheimer's 
disease are influenced by anesthetic agents, suggesting 
that an interaction between general anesthesia and 
Alzheimer's disease pathogenesis may underlie 
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POCD 12）. However, whether Mapt regulation in the 
brain is directly associated with general anesthesia or/
and surgical procedures in model mice with non-
Alzheimer conditions has not yet been reported. 
 Using transcriptome analysis, we reported that 
the comprehensive messenger RNA (mRNA) profile of 
neurons in the mouse hippocampus changes drastically 
following the simple exposure to sevoflurane 13）. These 
changes in the hippocampus suggest that simple 
sevoflurane anesthesia may induce neuroinflammation. 
Le Freche et al. have demonstrated that simple sevoflurane 
exposure is also associated with spatial cognitive 
deficits and increased tau phosphorylation via the 
activation of specific kinases 14）. Some strategies and 
mechanisms for preventing cognitive deficits resulting 
from neuroinflammation and neurodegeneration have 
been reported. For example, high-mobility group box 1 
(HMGB1) is upregulated in the brain and cerebrospinal 
fluid following surgery 15）, and the suppression of HMGB1 
downregulates the expression of inflammatory pathway-
related genes in aged rats 16）. Acetyl-l-carnitine may have 
neuroprotective effects on lipopolysaccharide (LPS)-induced 
neuroinflammation in mice via the regulation of brain-
derived neurotrophic factor (BDNF) 17）. 
 Dexmedetomidine is a highly selective α2 adrenergic 
agonist with effects on the human brain, including sedation, 
anesthesia, and analgesia 18, 19）. Dexmedetomidine also 
has anti-inflammatory effects and suppresses inflammatory 
pathways 20）. We hypothesized that the impairment of 
cognitive function due to surgery-induced inflammation 
and the mRNA expression change of several related genes 
in the hippocampus were alleviated by dexmedetomidine. 
This study aimed to verify the transcriptional network 
changes in the hippocampus of aged mice following 
sevoflurane/surgery-induced stress and to determine 
how dexmedetomidine affects postoperative cognitive 
function using the Barnes Maze test.
2.　Material and Methods
2・1　Preparation of the animals
 With approval from the Sapporo Medical University 
School of Medicine animal ethics committee (project 
number: 15-031), male C57/BL6 mice (10 weeks of age, 
body weight of about 25 g) were purchased from Japan 
SLC, Inc. (Hamamatsu, Japan) and housed at 22℃ under 
controlled lighting conditions (12:12-hour light/dark 
cycle); they were provided free access to food and water. 
All mice used in this experimental protocol were 
housed under similar circumstances until they were 
54-56 weeks of age and were then used for the experiments. 
All experimental treatments were performed following 
the animal guidelines of our institution, the National 
Institutes of Health Guide for the Care and Use of 
Laboratory animals 21）, and the International Association 
for the Study of Pain rules 22）.
2・2　Transcriptome analysis
 Twelve aged male mice were assigned into two 
groups: (1) Naïve group (n = 6) and (2) Operation group 
(Ope group, n = 6) (Fig. 1A). The mice in the Naïve 
group were provided 100% oxygen alone for 1 hour 
after they were placed in a plastic chamber without 
being administered an anesthetic agent. The mice in 
the Ope group were anesthetized with 2.5% sevoflurane 
(Maruishi Co., Ltd. Shizuoka, Japan) for 1 hour and 
provided 100% oxygen; a 15-20-mm longitudinal incision 
was then made into their lower abdomen, followed by 
intestinal manipulation during sevoflurane anesthesia. 
The incision was sewn and closed using 6.0 VICRYL 
PLUS  sutures (Johnson and Jonson, NJ). No critical 
blood loss was observed during the surgery and 
incision-closure procedures. All anesthetized mice 
showed spontaneous breathing, and their oxygen 
saturation was observed to be maintained at over 93% 
when they were monitored with a MouseSTAT Jr. system 
and a paw pulse oximeter sensor (Kent Scientific 
CORPORATION, CT). Their temperatures were monitored 
using a rectal probe and were observed to be maintained 
at over 37.0℃ during the treatments. Then, the mice were 
decapitated under sevoflurane anesthesia, and the 
brain of each mouse was immediately removed from 
the skull, frozen at -70℃ with 2-methylbutane, and placed 
in a Petri dish containing ice-cold phosphate-buffered 
saline. The brain was cut along the longitudinal fissure 
of the cerebrum, and the regions posterior to the 
lambda were cut off using tissue matrices (Brain 
Matrices, EM Japan, Tokyo, Japan). Thereafter, the 
brain was placed with the cortex of the left hemisphere 
facing down, and any non-cortical forebrain tissues 
were removed. Hippocampal blocks were obtained 
using Brain Matrices (EM Japan). Meningeal tissues 
were removed from the hemispheres according to a 
previously described method 23）. Finally, dissected 
hippocampal cells were homogenized and lysed, to 
prepare six RNA samples from each mouse using the 
RNeasy  Plus Micro Kit (Qiagen, Hilden, Germany) 
and QIAcube (Qiagen). Quality control for the isolated 
RNA samples was performed using the Agilent 2200 
67Postoperative cognitive deficit and Mapt expression in hippocampus
TapeStation system (Agilent Technologies, Santa 
Clara, CA). For the samples to pass the initial quality 
control step, the following criteria were used: > 1 μg of 
sample was obtained, and the equivalent RNA integrity 
number (eRIN) was ≥ 8. The eRIN was determined using 
a 2500 Bioanalyzer Instrument, which provides accurate 
information 24）. The isolated RNA was then pooled into 
two samples per group and labeled. A complementary 
DNA (cDNA) library was prepared using TruSeq  
RNA Library Prep Kits (Illumina, Inc., San Diego, CA), 
according to the manufacturer's instructions. RNA-seq 
was performed in the paired-end (101 cycles x 2) mode 
on an Illumina HiSeq 2500 platform (Illumina, Inc.). Base 
call (.bcl) files for each cycle of sequencing were generated 
using the Illumina Real Time Analysis software (Illumina, 
Inc.) and were analyzed primarily and de-multiplexed 
into a FASTQ file using Illumina's BCL2FASTQ conversion 
software (ver. 1.8.4, Illumina, Inc.). Raw paired-end 
RNA-seq reads in FASTQ formats were assessed for 
base call quality, cycle uniformity, and contamination 
using FastQC (http://www.bioinformatics.bbsrc.ad.uk/
projects/fastqc/). Mapping of the quality control-filtered 
paired-end reads to the mouse genome and quantification 
of the expression level of each gene were performed 
using R software (ver. 3.1.1 with TCC package) 25, 26）. 
The quality control-filtered paired-end reads were 
mapped to the public mouse genome data published by 
UCSC (NCBI37/mm9, http://genomes.UCSC.edu/). 
Figure 1. The protocol for the preparation of the animals. (A) Mice from both the Naïve and Ope groups were sacrificed after 60 minutes of 
the treatments, including the interventions, and the hippocampal sections of mice from each group were used for transcriptome 
analysis. (B) Similar to the protocol for transcriptome analysis, the mice from each group were sacrificed after 60 minutes of the 
treatments, and the hippocampal sections of the mice from the four groups were used for quantitative reverse transcription 
polymerase chain reaction. (C) Mice from each group were trained for 14 days and subjected to intervention. On the 7 th, 14 th, and 
28 th day after each intervention, a spatial test was performed using the Barnes Maze tracking system. 
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2・3 　Quantitative reverse transcription polymerase chain 
reaction (qRT-PCR)
 A separate set of mice was divided into four different 
experimental groups: (1) Naïve group (n = 7), (2) sevoflurane-
exposure group (Sevo group, n = 7), (3) Ope group (n = 7), 
and (4) dexmedetomidine (Maruishi Pharmaceutical, 
Osaka, Japan)-injection group (Dex group, n = 7) (Fig. 1B). 
The mice in the Naïve and Ope groups were treated as 
described for the transcriptome analysis procedure. 
The mice in the Sevo group were anesthetized with 
2.5% sevoflurane for 1 hour in the presence of 100% 
oxygen after being placed in a plastic chamber. The 
mice in the Dex group were intraperitoneally (i.p.) 
administered with 10 μg/kg dexmedetomidine diluted 
in 0.1 ml of normal saline 30 minutes before the operation. 
The total RNAs from the mice in each group were 
isolated from the hippocampi of their frozen brain tissues 
by using an RNeasy Mini Kit (Qiagen), according to 
the manufacturer's standard protocol. The concentration 
and purity of the isolated RNA samples were assessed 
using a NanoDrop 1000 spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA). cDNAs were generated 
by reverse transcription PCR using the QuantiTect 
Reverse transcription Kit (Qiagen). For qRT-PCR, an 
SYBR Green QuantiTect Primer Assay (Qiagen, ID: 
QT00100170) specific for Mapt was used to quantify the 
mRNA expression levels, according to the manufacturer's 
instructions. Target gene expression was analyzed 
using the comparative CT method, using Gapdh_3 _SG 
(Qiagen, ID: QT01658692) as the control 27）.
2・4　Behavioral test
 Cognitive function before and after the intervention 
was evaluated via the Barnes Maze test by using a 
computerized video tracking system 28）. Training was 
performed for 14 days. For the training session, the 
animals were maintained in the same housing conditions 
throughout the test. The room temperature was maintained 
at 23℃ , and the room was kept quiet during the test. 
In all trials, the mice were first placed in the middle of 
a circular platform with 20 equally spaced holes. One 
of these holes was connected to a dark chamber called 
the target box. Once the mouse entered the target box, 
the trial was finished, and the mouse was allowed to 
stay in the target box for 30 seconds. If the mouse failed to 
find the target box within 180 seconds, it was manually 
guided to the target box and allowed to remain in the 
hole for 30 seconds. Two trials were conducted per day 
for 14 days, and the target box remained at the same 
location throughout the test. The amount of time spent 
finding and entering the target box (latency: seconds), 
the distance traveled to enter the box (distance: cm), and 
percent time in the quadrant were determined from the 
video tracking system (Lime Light 4, ACTIMETRICS, 
Wilmette, IL). The memory test was performed after the 
respective treatments at three-time points: postoperative 
days 7, 14, and 28. (Fig. 1C)
2・5　Statistical analysis
 For transcriptome analysis, sets of genes showing 
differential expression were filtered to remove those 
with fold changes < 1.5 (upregulated or downregulated) 
and with a false discovery rate-corrected p value of > 
0.05. The sample size was calculated with the following 
parameters: power ≥ 0.8, probability level < 0.05, and 
anticipated effect size = 14. In the qRT-PCR analysis, 
data were analyzed using one-way ANOVA with post-
hoc Bonferroni correction. For the Barnes Maze test, 
the data were expressed as the mean ± standard deviation 
(S.D.). The behavioral data were analyzed using repeated 
ANOVA, followed by the Student-Newman-Keuls multiple-
range test for post hoc comparisons. All analyses were 
performed using a statistical software (GraphPad Prism 
6, GraphPad, San Diego, CA). p < 0.05 was considered 
statistically significant for all the experiments.
3.　Results
3・1　Transcriptome Analysis
 Four RNA samples from mice in each group 
had a quality of ≥ 1 μg and an eRIN value of ≥ 8. We 
investigated the changes in the expression levels of a 
total of 37,682 genes. A total of 2,786 genes were filtered 
because of little change in their mRNA expression levels. 
Microarray plotting revealed a total of 943 genes that 
showed differential expression among the mice from 
the two groups (Fig. 2). We detected 752 upregulated 
and 191 downregulated genes. Table 1 shows the top 
20 genes that were highly upregulated after sevoflurane/
surgery-induced stress. Among them, the isocitrate 
dehydrogenase 3 (NAD+) beta (Idh3b) gene was the 
most upregulated gene. This gene encodes the β subunit 
of isocitrate dehydrogenase 3, a mitochondrial enzyme 
of the tricarboxylic acid cycle. Besides, Idh3b encodes a 
possible apoptogenic factor that functions much like the 
cytochrome c released in mammalian cells and mediates 
cell death 29, 30）. Mapt, which is the focus of this study, 
showed a log2 ratio of 3.38, indicating that it was highly 
upregulated. Table 2 shows the top 20 most highly 
downregulated genes. The gene encoding late cornified 
envelope 3D (Lce3d) was the most downregulated gene. 
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Figure 2. Changes in the expression levels of genes using microarray plotting. The horizontal axis shows the average expression levels of 
genes in samples from mice in the Naïve and Ope groups. The vertical axis shows the tendency of gene expression in samples from 
mice in the Ope group, compared to those from mice in the Naïve group. The gray circles represent the differentially expressed 
genes (DEGs) and the black circles represent the non-DEGs.
Table 1. Top 20 genes that were highly upregulated in the hippocampi 
of aged mice following surgery and sevoflurane exposure.
Gene name Gene description log2 ratio
Idh3b isocitrate dehydrogenase 3(NAD+) beta 9.64
Tmpo thymopoietin 8.05
Galnt11 UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 11 7.38
Prkab1 protein kinase, AMP-activated, beta 1 non-catalytic subunit 6.78
Cbx7 chromobox7 6.67
Hcn1 hyperpolarization-activated, cyclic nucleotide-gated K+1 6.44
Synpo2 synaptopodin2 6.31
Syt2 synaptotagmin2 5.72
Xlr X-linked lymphocyte-regulated 5.68
Kcnd3 potassium voltage-gated channel, Shal-related family, member 3 5.62
Il1f5 interleukin 1 family, member 5 (delta) 5.61
Agfg2 ArfGAP with FG repeats 2 5.56
Ttc19 tetratricopeptide repeat domain 19 5.25
Cox7b2 cytochrome c oxidase subunit 7b2 5.18
Wdr37 WD repeat domain 37 5.18
Gm5431 predicted gene 5431 5.15
Ippk inositol 1,3,4,5,6-pentakisphosphate 2-kinase 5.12
Gpr135 G protein-coupled receptor 135 5.09
Psmd1 proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 5.08
Bst2 bone marrow stromal cell antigen 2 4.96
Table 2. Top 20 genes that were highly downregulated in the hippocampi 
of aged mice following surgery and sevoflurane exposure.
Gene name Gene description log2 ratio
Lce3d late cornified envelope 3D -6.44
Rtn4r reticulon 4 receptor -5.95
Mansc1 MANSC domain containing 1 -4.86
Zbed3 zinc finger, BED type containing 3 -4.67
2010106E10 
Rik RIKEN cDNA 2010106E10 gene -4.66
Trmt2b TRM2 tRNA methyltransferase 2B -4.36
Cldn5 claudin 5 -4.33
Chia1 chitinase, acidic 1 -4.32
Actl7b actin-like 7b -4.28
Arl4d ADP-ribosylation factor-like 4D -4.24
Mir299b micro RNA 299b -4.21
Uqcrc2 ubiquinol cytochrome c reductase core protein 2 -4.11
Gpr182 G protein-coupled receptor 182 -3.99
Hoxb5 homeobox B5 -3.96
Sptal1 spectrin alpha, erythrocytic 1 -3.96
Cdv3 carnitine deficiency-associated gene expression in ventricle 3 -3.89
Tmed7 transmembrane p24 trafficking protein 7 -3.79
AF366264 cDNA sequence AF 366264 -3.7
Tsga10 testis specific 10 -3.68
Fcgr4 Fc receptor, IgG, low affinity IV -3.53
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3・2　qRT-PCR
 Mapt is a neuronal protein that is highly enriched 
in axons and is important for neuronal development 
and the control of neurological degeneration. Mapt was 
highly upregulated in mice from the Ope group, compared 
to the case for those from both the Naïve and Sevo 
groups (p < 0.01). Mapt was remarkably downregulated 
in the mice from the Dex group, compared to the case 
for those from the Ope group (p < 0.01) (Fig. 3). 
3・3　Barnes Maze test
 We found no difference between the cognitive 
function of the mice from the different groups on day 1. 
The time taken (seconds) and the distance travelled 
(cm) to enter the target box during the 14-day training 
sessions in the Barnes maze test gradually decreased 
in case of mice from all the groups (Fig. 4 and Fig. 5). 
The time taken and distance traveled to enter the 
target box on day 14 were significantly lower than 
those on day 1. When the cognitive function of the mice 
was tested on postoperative day seven after the training 
sessions, the time spent by the mice subjected to surgery 
to identify the target box was longer than that in case 
of the mice from the other three groups. However, this 
increase in the time was attenuated by dexmedetomidine 
intervention. A similar pattern was observed on 
postoperative day 14 after the training sessions. On 
postoperative day 28, the time taken by the mice from 
the Ope group to enter the box was longer than that 
taken by the mice from the other groups to enter the 
box. On days 7 and 14 after the training sessions, the 
distance traveled by the mice from the Ope group to 
enter the target box was significantly longer than that 
in case of the mice from the other three groups. The 
Figure 3. The fold change of Mapt expression in samples from mice 
in the Naïve, Sevo, Ope, and Dex groups. The expression 
level of Mapt is shown as the mean ± SD. In the 
samples from mice in the Ope group, the fold change 
was 2.60 ± 0.77. The post hoc-adjusted p value is *p < 
0.01 versus other groups. The mice in the Sevo group were 
only exposed to sevoflurane, those in the Ope group 
underwent surgery during sevoflurane exposure, and 
those in the Dex group received dexmedetomidine 
intraperitoneally before the surgery.
Figure 4. Changes in latency (seconds) from the training to the test session. After 14 days of the training sessions, the time spent to identify 
the target box (seconds) gradually decreased. On postoperative days 7, 14, and 28, the mice in the Ope group needed more time to 
find the hole compared to those from the other groups (*p < 0.05). Dexmedetomidine alleviated the sevoflurane/surgery-induced 
cognitive deficit. The cognitive function of mice from each group is exacerbated compared to that on the 14 th training day ( † p＜0.05).
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percent time spent in the quadrant with the target box 
was not significantly different among the mice from 
the different groups (Data not shown.).
4.　Discussion
4・1　The aged mouse model
 The molecules in mice that regulate cell differentiation 
and death are similar to those in humans 31）. Moreover, 
the aging process between mice and humans is also 
similar 32）. The findings obtained from the experiments 
using aged mice can be considered similar to the changes 
that occur in elderly humans. In this experimental 
protocol, we housed all mice under similar circumstances 
until they were 54-56 weeks of age, which is equivalent 
to the conditions observed in at least middle-aged or 
older humans.
4・2　Transcriptome analysis
 Recent progress in genomics has enabled us to 
comprehensively analyze cellular modifications at the 
gene expression level. The DNA microarray technique 
has revealed various mechanisms underlying diseases; 
however, only a few investigations of the association 
between POCD and the hippocampus have been performed 
via a transcriptome-wide association study. Transcriptome 
analysis can capture both coding and non-coding RNAs 
and quantify the heterogeneity of gene expression 
using samples from various tissues. This analysis has 
some advantages 33）. Functional characterization and 
annotation of genes are possible, and researchers can 
reconstruct genetic interaction networks 34） and identify 
clues related to disease processes and prognoses 35, 36）. 
In our experimental protocol, as the first step, we 
performed whole-transcriptome analysis to investigate 
the differences between the gene expression in the 
hippocampi of mice from the Naïve and Ope groups. In 
a clinical study involving humans, Peffers et al. have 
demonstrated that drastic changes in RNA occur at 
numerous genomic levels, indicating that the regulation 
of transcriptional networks is involved in aging-associated 
degeneration 37）. Additionally, Broad et al. have revealed 
that surgery-induced cell death is significantly increased 
in the brains of developing piglets. Using RNA sequence 
data, this group has identified changes in the expression 
of gene transcripts following the administration of 
isoflurane anesthesia alone, compared to that following 
surgery 38）. These findings indicate that transcriptome 
analysis is useful for investigating differences in gene 
expression before and after an intervention, and can 
identify the association between these changes and the 
mechanisms underlying these phenomena. In our 
study, we detected all the upregulated and downregulated 
Figure 5. Changes in latency (distance) from the training to the test session. After 14 days of the training sessions, the distance travelled to 
identify the target box (cm) gradually decreased. On postoperative days 7 and 14, the mice in the Ope group travelled a longer 
distance to find the hole compared to those in the other groups (*p < 0.05). Dexmedetomidine alleviated the sevoflurane/surgery-
induced cognitive deficit. The cognitive function of mice from each group is exacerbated compared to that on the 14 th training day 
( † p ＜0.05). 
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genes whose expression levels were affected by surgery-
induced stress, and identified several target genes that 
may be related to postoperative cognitive deficits. 
According to the transcriptome analysis in this study, 
Mapt may be an important target gene that is strongly 
associated with sevoflurane/surgery-induced stress.
4・3　Mapt
 Mapt is expressed in the central nervous system 
and encodes the tau protein. The tau protein is 
necessary for maintaining axonal function, and it plays 
a role in axonal transport 39, 40）, synaptic plasticity 41, 42）, and 
nucleic acid protection 43, 44）. However, once abnormal 
external stress and neuronal cell death occur in the brain, 
the tau protein accumulates, causing tauopathies, which 
are one of the causes of, and pathogenic mechanisms 
underlying, neurodegenerative diseases such as Alzheimer's 
disease, 45） frontotemporal lobar degeneration (FTLD) 46, 47）, 
and post-traumatic brain injury 48）. The influence of 
tauopathies on cognitive function appears to be strong 
in aged individuals and is the reason for the decrease 
in cerebral metabolism in elderly people. From the 
results of this study, we suggest two possibilities for 
the significant increase in the Mapt expression level in 
the hippocampi of the aged mice. The Mapt expression 
may have increased directly as a consequence of the 
surgical procedure and/or indirectly due to the suppression 
of the metabolism in the brain. The expression level of 
Mapt may be associated with the pathogenesis of 
behavioral dysfunction, and serves as a biomarker in 
the hippocampus of mice, indicating sevoflurane/
surgery-induced cognitive deficit. In a surgical model, 
under general anesthesia, systemic inflammation 
spreads in the brain and affects the expression level of 
Mapt. We suppose that short-term surgical stress may 
lead to changes in the hippocampus that are similar to 
those observed in case of age-related degeneration.
4・4 　Dexmedetomidine inhibits sevoflurane/surgery-
induced upregulation of Mapt expression
 Dexmedetomidine, a selective α2 adrenergic 
receptor agonist, is used clinically for perioperative 
sedation and anesthesia 49, 50）. In addition, dexmedetomidine 
elicits anti-inflammatory effects via the modulation of 
several pathways, such as the cholinergic anti-inflammatory 
pathway and the NF-κB pathway 51, 52）, and suppresses 
postoperative agitation and emergence delirium. Paeschke 
et al. have investigated whether the gene expression of 
interleukin-1β (IL-1β) and tumor necrosis factor-α 
(TNF-α), and the expression of the microRNAs miR124, 
132, 134, and 155 in the adult rat hippocampus, cortex, 
and plasma changed after the intraperitoneal administration 
of 1 mg/kg LPS in the presence or absence of 5 µg/kg 
dexmedetomidine 53）. Dexmedetomidine significantly 
suppressed LPS-induced neuroinflammation in the 
hippocampus and cortex via the reduction of the IL-1β and 
TNF-α gene expression after 24 hours, and drastically 
decreased the expression of microRNAs in both these 
regions of the brain. Moreover, dexmedetomidine elicits 
a direct neuroprotective effect via BDNF induction and 
an indirect neuroprotective effect by promoting the 
release of BDNF from astrocytes 54）. 
 In our study, we injected 10 μg/kg dexmedetomidine 
into the mice from the Dex group before the surgery. 
All mice received a mild sedative without down saturation. 
In previous studies, the intensity of invasive stress and 
the severity of inflammation have been reported to be 
different, and the dexmedetomidine doses administered 
also varied. Xiong et al. have stated that 12 μg/kg represents 
a high dose, and 3 μg/kg represents a low dose of 
dexmedetomidine 55）. Thus, the dose of dexmedetomidine 
that we used in our protocol (10 μg/kg) was quite reasonable. 
Dexmedetomidine may attenuate the upregulation of 
Mapt expression via several pathways and elicit a 
neuroprotective effect. 
4・5 　Dexmedetomidine may attenuate sevoflurane/
surgery-induced cognitive deficit
 This study demonstrated that dexmedetomidine 
attenuated sevoflurane/surgery-induced cognitive deficit 
by downregulating the Mapt expression. This result 
may explain one of the possible mechanisms underlying 
the effects of dexmedetomidine and become a key to 
prevent cognitive deficit. The results of the Barnes 
Maze test showed that the latency in case of the mice 
from the Ope group was significantly longer than that 
in case of the mice from the Naïve group on the 7th, 
14th, and 28th day after surgery, and that the distance 
travelled by the mice from the Ope group was 
significantly longer than that travelled by the mice 
from the Naïve group on the 7th and 14th day after 
surgery. Dexmedetomidine intervention prior to the 
open abdominal surgery shortened the time latency in 
case of the mice from the Ope group on the 7th, 14th, 
and 28th day after surgery, and the distance travelled 
on the 7th and 14th day after surgery. These results 
suggested that dexmedetomidine may be effective for 
improving the sevoflurane/surgery-induced cognitive 
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deficit or for maintaining cognitive function following 
surgery-induced stress. Xiong et al. have also reported 
that dexmedetomidine may limit the degree of expression 
of relaxin-3 and the overexpression of c-fos in the 
hippocampus, downregulate the expression of pro-
apoptosis proteins such as Fas, caspase-8, and caspase-9, 
and upregulate the expression of the anti-apoptosis 
protein Bcl-2 55）. Yamanaka et al. have also shown that 
early dexmedetomidine treatment attenuates these 
systemically induced neurocognitive changes by 
preventing subsequent hippocampal neuroinflammation 
and the overexpression of TLR-4 in the microglia 56）. 
Our results are consistent with these previous results.
4・6　Limitations
 This study has some limitations. We observed only 
the mRNA expression changes in the hippocampus 
and did not investigate the related downstream 
pathways. We focused on the fluctuation of Mapt 
expression in cognitive dysfunction; however, other 
genes may be involved in this process as well. Indeed, 
the results of the transcriptome analysis showed that 
many genes were upregulated; however, we could not 
clearly identify which gene is the most important. 
Mapt, which has been suggested to be relevant to 
cognitive function in this study, was the only clue 
uncovered in this study. To confirm the sequential 
phenomena caused by dexmedetomidine injection, we 
need to perform the same protocol in the Mapt-
knockout mice.
 In this experimental protocol, we observed relatively 
early behavioral changes at 7, 14, and 28 days after the 
intervention. Based on the results of this study, we 
could not conclude whether these behavioral changes 
were caused by postoperative delirium or cognitive 
dysfunction, because we could not precisely define the 
boundary between these phenomena.
 The analgesic effect of dexmedetomidine may have 
influenced the behavioral changes after intervention. 
However, since both the blood and tissue concentrations 
of dexmedetomidine were not examined in this 
experimental protocol, it is impossible to demonstrate 
how dexmedetomidine directly affects cognitive 
behavior after the intervention. In this experimental 
protocol, transcriptome analysis of the samples from 
the mice in the Dex group was not performed, and only 
the comparison between the samples from mice in the 
Naïve and Ope groups is conducted; a standard 
transcriptome analysis method to examine the samples 
from mice in multiple groups has not been established. 
In order to clarify the mechanisms underlying the 
effects of dexmedetomidine, the transcriptome analysis 
of the samples from mice in the Dex group may also be 
needed.
5.　Conclusions
 In conclusion, dexmedetomidine attenuates 
sevoflurane/surgery-induced cognitive deficit and the 
hippocampal Mapt expression in aged mice. Although 
further experiments and analyses are needed to 
confirm these results, our findings suggest that POCD 
may be attenuated by suppressing the Mapt expression 
in the hippocampus.
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を投与）の 4 群に分類し，qRT-PCR で海馬における









2.60 ± 0.77 vs Naive 群 1.00 ± 0.11 [mean fold 
change ± SD], p< 0.01）．バーンズメイズ試験では，
麻酔・手術侵襲によってターゲットボックス認知まで
の時間は延長したが，デクスメデトミジン投与によっ
て認知時間延長が抑制された．
結論
　デクスメデトミジンは，セボフルラン暴露下での手
術侵襲による認知機能低下を減弱し，かつ，高齢マウ
スの海馬における Mapt 発現を抑制する．
